Whether patients and health plans prefer branded apixaban at $100 per month over generic apixaban at $15 per month is an open question
Hydration cannot be overemphasized
Ruggenenti P, Porrini E, Motterlini N, Perna A, Ilieva AP, Iliev IP, et al
What the research shows about inflammation reduction with GLP-1 medications Emerging studies suggest that GLP-1 medications may reduce these inflammatory markers: In several lab and animal studies modeling neurodegenerative diseases, activating the GLP-1 receptor in the brain consistently reduced inflammation and promoted neuroprotection
Wellbutrin is FDA-approved for the treatment of major depressive disorder, seasonal affective disorder, and smoking cessation
Whilst these drugs offer significant metabolic benefits, understanding their potential impact on skeletal health is essential for comprehensive patient care